Nombre del producto:3,4-Dihydro-2H-pyrano[2,3-c]pyridine-6-carbaldehyde

IUPAC Name:2H,3H,4H-pyrano[2,3-c]pyridine-6-carbaldehyde

CAS:527681-61-4
Fórmula molecular:C9H9NO2
Pureza:95%+
Número de catálogo:CM253424
Peso molecular:163.18

Unidad de embalaje Stock disponible Precio($) Cantidad
CM253424-250mg in stock ƥǵǵ
CM253424-1g 1-2 Weeks ůƓů

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :527681-61-4
Fórmula molecular:C9H9NO2
Punto de fusión:-
Código de sonrisas:O=CC1=CC(CCCO2)=C2C=N1
Densidad:
Número de catálogo:CM253424
Peso molecular:163.18
Punto de ebullición:287.8±28.0°C at 760 mmHg
Nº Mdl:MFCD18802894
Almacenamiento:Keep in Inert atmosphere, store in freezer, under -20°C.

Column Infos

Gepotidacin
GSK announces positive headline results from the EAGLE-1 Phase III trial for Gepotidacin in uncomplicated urogenital gonorrhea. Gonorrhoea is the second most common sexually transmitted infection due to the pathogen N. gonorrhoeae. Untreated urogenital gonorrhea can cause serious and permanent health problems, such as pelvic inflammatory disease and infertility.
Gepotidacin is an investigational, first-in-class inhibitor of bacterial topoisomerase. It has a distinct mechanism of action that inhibits bacterial DNA replication by selectively interacting with two key bacterial enzymes, DNA gyrase and topoisomerase IV. Gepotidacin confers activity against most strains of E. coli and S. saprophyticus, and N. gonorrhoeae, including target pathogens resistant to current antibiotics.